Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Marshall

Showing results (171-180 of 228) with videos related to

Pageof 23
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2000
Activity of thalidomide in AIDS-related Kaposi's sarcomaR F Little, K M Wyvill, J M Pluda, et al.
Biomedical Optics Express|January 25, 2011
Direct evidence of lymphatic function improvement after advanced pneumatic compression device treatment of lymphedemaKristen E Adams, John C Rasmussen, Chinmay Darne, et al.
European Journal of Cancer (Oxford, England : 1990)|June 22, 2021
Phase 1 dose-escalation and pharmacokinetic study of regorafenib in paediatric patients with recurrent or refractory solid malignanciesBirgit Geoerger, Bruce Morland, Irene Jiménez, et al.
The Lancet. Oncology|November 30, 2019
Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1-2 studyBirgit Geoerger, C Michel Zwaan, Lynley V Marshall, et al.
Journal of Pediatric Hematology/Oncology|December 11, 2013
Toxicity and outcome of children and adolescents participating in phase I/II trials of novel anticancer drugs: the Royal Marsden experienceDaniel A Morgenstern, Darren Hargrave, Lynley V Marshall, et al.
European Radiology|March 17, 2015
Demonstration of the reproducibility of free-breathing diffusion-weighted MRI and dynamic contrast enhanced MRI in children with solid tumours: a pilot studyKeiko Miyazaki, Neil P Jerome, David J Collins, et al.
Pediatric Blood & Cancer|September 13, 2016
Feasibility and applicability of diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging in routine assessments of children with high-grade gliomasFernando Carceller, Neil P Jerome, Keiko Miyazaki, et al.
European Radiology|March 23, 2016
Repeatability of derived parameters from histograms following non-Gaussian diffusion modelling of diffusion-weighted imaging in a paediatric oncological cohortNeil P Jerome, Keiko Miyazaki, David J Collins, et al.
European Journal of Cancer (Oxford, England : 1990)|May 13, 2023
Afatinib in paediatric patients with recurrent/refractory ErbB-dysregulated tumours: Results of a phase I/expansion trialBirgit Geoerger, Lynley V Marshall, Karsten Nysom, et al.
The Lancet. Oncology|November 15, 2021
Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion studyMatthias Fischer, Lucas Moreno, David S Ziegler, et al.
Pageof 23

Showing results (171-180 of 228) with videos related to

Sort By:
Pageof 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2000
Activity of thalidomide in AIDS-related Kaposi's sarcomaR F Little, K M Wyvill, J M Pluda, et al.
Biomedical Optics Express|January 25, 2011
Direct evidence of lymphatic function improvement after advanced pneumatic compression device treatment of lymphedemaKristen E Adams, John C Rasmussen, Chinmay Darne, et al.
European Journal of Cancer (Oxford, England : 1990)|June 22, 2021
Phase 1 dose-escalation and pharmacokinetic study of regorafenib in paediatric patients with recurrent or refractory solid malignanciesBirgit Geoerger, Bruce Morland, Irene Jiménez, et al.
The Lancet. Oncology|November 30, 2019
Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1-2 studyBirgit Geoerger, C Michel Zwaan, Lynley V Marshall, et al.
Journal of Pediatric Hematology/Oncology|December 11, 2013
Toxicity and outcome of children and adolescents participating in phase I/II trials of novel anticancer drugs: the Royal Marsden experienceDaniel A Morgenstern, Darren Hargrave, Lynley V Marshall, et al.
European Radiology|March 17, 2015
Demonstration of the reproducibility of free-breathing diffusion-weighted MRI and dynamic contrast enhanced MRI in children with solid tumours: a pilot studyKeiko Miyazaki, Neil P Jerome, David J Collins, et al.
Pediatric Blood & Cancer|September 13, 2016
Feasibility and applicability of diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging in routine assessments of children with high-grade gliomasFernando Carceller, Neil P Jerome, Keiko Miyazaki, et al.
European Radiology|March 23, 2016
Repeatability of derived parameters from histograms following non-Gaussian diffusion modelling of diffusion-weighted imaging in a paediatric oncological cohortNeil P Jerome, Keiko Miyazaki, David J Collins, et al.
European Journal of Cancer (Oxford, England : 1990)|May 13, 2023
Afatinib in paediatric patients with recurrent/refractory ErbB-dysregulated tumours: Results of a phase I/expansion trialBirgit Geoerger, Lynley V Marshall, Karsten Nysom, et al.
The Lancet. Oncology|November 15, 2021
Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion studyMatthias Fischer, Lucas Moreno, David S Ziegler, et al.
Pageof 23